Literature DB >> 17512573

PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.

Thomas Quéméneur1, Françoise Martin-Nizard, Abdelmejid Kandoussi, Xavier Kyndt, Philippe Vanhille, Eric Hachulla, Pierre-Yves Hatron, Jean-Charles Fruchart, Patrick Duriez, Marc Lambert.   

Abstract

OBJECTIVES: Because systemic vasculitis (SV) predisposes to atherosclerosis, and high-density lipoprotein (HDL) prevents atherosclerosis by "reverse cholesterol transport" and by inhibiting low-density lipoprotein (LDL) oxidation thanks to apolipoprotein A-I (Apo-AI) and paraoxonase 1 (PON1), we assessed whether LDL oxidation was increased in SV and associated with less PON1 activity.
METHODS: The sera of 33 patients with active SV (ASV), 32 in full remission of SV (RSV) and 20 healthy subjects (HS) were analyzed for C-reactive protein (CRP), high-sensitivity-CRP, lipids, lipoproteins, apolipoproteins, PON1 activity, LDL-immune complexes (LDL-IC), and auto-antibodies to oxidized-LDL (ox-LDL), and anticardiolipin antibodies.
RESULTS: CRP was higher in ASV than RSV and HS, and negatively correlated with HDL-cholesterol and Apo-AI. Autoantibodies to ox-LDL and highly oxidized malondialdehyde-LDL were higher in RSV than ASV and HS (P<0.05). LDL-IC titers were higher in ASV than RSV and HS (P<0.05). PON1 activity was lower in ASV and RSV than HS (P=0.02). A trend toward a negative correlation between basal PON1 activity and anti-MDA-LDL antibodies (P=0.06) was observed.
CONCLUSION: Inflammatory markers in SV were associated with a modified lipoprotein profile, which could lower PON1 activity and contribute to increased ox-LDL titers and accelerated atherosclerosis development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512573     DOI: 10.1016/j.semarthrit.2007.03.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  7 in total

1.  Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis.

Authors:  Boris L Vaisman; Stephen J Demosky; John A Stonik; Mona Ghias; Cathy L Knapper; Maureen L Sampson; Cuilian Dai; Stewart J Levine; Alan T Remaley
Journal:  J Lipid Res       Date:  2011-10-27       Impact factor: 5.922

2.  Serum paraoxonase activity and lipid hydroperoxide levels in adult football players after three days football tournament.

Authors:  M Atli
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

3.  Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis.

Authors:  Ramazan Esen; Mehmet Aslan; Mehmet Emin Kucukoglu; Aytekin Cıkman; Umit Yakan; Mahmut Sunnetcioglu; Sahbettin Selek
Journal:  Wien Klin Wochenschr       Date:  2015-02-24       Impact factor: 1.704

4.  Proteomic Profiling of Cryoglobulinemia.

Authors:  Peng Liu; Jianqiang Wu; Dandan Sun; Haolong Li; Zhihong Qi; Xiaoyue Tang; Wei Su; Yongzhe Li; Xuzhen Qin
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

5.  High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis.

Authors:  Jozélio Freire de Carvalho; Eloísa Bonfá; Mailze C Bezerra; Rosa Maria Rodrigues Pereira
Journal:  Clin Rheumatol       Date:  2009-03-13       Impact factor: 2.980

6.  Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism.

Authors:  Adriana Santi; Marta M M F Duarte; Charlene C de Menezes; Vania Lucia Loro
Journal:  Int J Endocrinol       Date:  2012-11-29       Impact factor: 3.257

7.  Paraoxonase 1 activities and its gene promoter single nucleotide polymorphisms (-108, -126, and -162) in diabetes mellitus.

Authors:  Asefesadat Emami; Mohamadhasan Tajadini; Mehrdad Zeinalian; Mahtab Keshvari; Sedigheh Asgary
Journal:  Interv Med Appl Sci       Date:  2018-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.